pegyliposomal doxorubicin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for pegyliposomal doxorubicin, covering 2020-08-24 to 2020-08-24. Get the full timeline:
Most recent: Clinical Trial Update: Pegliposomal Doxorubicin and 5-fluorouracil as Second Line Therapy for Metastatic Gastric Cancer [Phase 2]